Prevalence and Perceived Financial Costs of Marijuana Versus Tobacco Use Among Urban Low-Income Pregnant Women
Overview
Affiliations
Objective: To examine the relative prevalence of marijuana and tobacco use among low-income post-partum women, using self-report, urine, and hair testing data; and to further explore perceptions of the substances among postpartum women by evaluating perceived risk and monetary cost of prenatal marijuana versus tobacco use.
Methods: Data from two studies were available for a total of 100 (Study 1) and 50 (Study 2) low-income, primarily African-American post-partum women. Study 1 participants completed brief self-report measures of substance use as well as urine and hair samples; study 2 participants completed a brief opinion survey regarding the risks and monetary costs of prenatal marijuana use.
Results: In Study 1, the self-reported prevalence of any tobacco or marijuana use in the past three months was 17% and 11%, respectively. However, objectively-defined marijuana use was more prevalent than self-reported tobacco use: 14% tested positive for marijuana by urinalysis, and 28% by hair analysis. Study 2 participants were more likely to believe that there is a safe level of marijuana use during pregnancy, and nearly half believed that using marijuana during pregnancy was less expensive than smoking cigarettes.
Conclusion: Marijuana use may be as or more prevalent than tobacco use among low-income, African-American pregnant women. These findings may in part be attributable to perceptions of roughly equivalent cost and the lack of a clear public health message regarding prenatal marijuana use, combined with growing pro-marijuana advocacy. A broader public health response to address prenatal marijuana use, along with other substances of abuse, is needed.
Emerging trends in cannabis administration for women with chronic pain.
Cameron E, Jacquin K Mental Health Sci. 2025; 2(4.
PMID: 39816373 PMC: 11735029. DOI: 10.1002/mhs2.88.
Wohrer F, Ngo H, DiDomenico J, Ma X, Roberts M, Bakhireva L Front Hum Neurosci. 2024; 18:1323297.
PMID: 38445095 PMC: 10912531. DOI: 10.3389/fnhum.2024.1323297.
Allen S, Natale B, Ejeckam A, Lee K, Hardy D, Natale D Cannabis Cannabinoid Res. 2024; 9(3):766-780.
PMID: 38364116 PMC: 11304342. DOI: 10.1089/can.2023.0166.
Marijuana Use among Pregnant and Nonpregnant Women of Reproductive Age, 2013-2019.
Kobernik E, Ford N, Levecke M, Galang R, Hoots B, Roehler D Subst Use Misuse. 2023; 59(5):690-698.
PMID: 38132561 PMC: 11000143. DOI: 10.1080/10826084.2023.2294974.
Cannabis and Pregnancy: A Review.
Hayer S, Mandelbaum A, Watch L, Ryan K, Hedges M, Manuzak J Obstet Gynecol Surv. 2023; 78(7):411-428.
PMID: 37480292 PMC: 10372687. DOI: 10.1097/OGX.0000000000001159.